Inhibition of MAP Kinase Kinase (MEK) Results in an Anti-inflammatory Response in Vivo
- 16 February 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 268 (2), 647-651
- https://doi.org/10.1006/bbrc.2000.2184
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharideBiochemical Pharmacology, 1997
- Mitogen-activated Protein (MAP) Kinase Regulates Production of Tumor Necrosis Factor-α and Release of Arachidonic Acid in Mast CellsPublished by Elsevier ,1997
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997
- The Effects of IL-1 on Mitogen-Activated Protein Kinases in Rabbit Articular ChondrocytesBiochemical and Biophysical Research Communications, 1997
- Inhibition of MAP kinase kinase (MEK) blocks endothelial PGI2 release but has no effect on von Willebrand factor secretion or E‐selectin expressionFEBS Letters, 1996
- Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal applicationBiochemical Pharmacology, 1995
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Cellular and Topical in vivo Inflammatory Murine Models in the Evaluation of Inhibitors of Phospholipase A2Skin Pharmacology and Physiology, 1995
- Interleukin 1 and tumour necrosis factor activate the mitogen‐activated protein (MAP) kinase kinase in cultured cellsFEBS Letters, 1993
- Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis InhibitorsAnnals of the New York Academy of Sciences, 1993